Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Originally created as a lipolytic compound for treating obesity, AOD-9604 has demonstrated potential in animal studies for treating heart disease, osteoarthritis, and metabolic syndrome by promoting cartilage repair and fat breakdown while inhibiting fat creation
Participants who took semaglutide (Ozempic) over the course of 68 weeks in a clinical trial lost an average of 15% of their body weight
This consultation costs 100 and is a one-off payment for new patients only
Unlike flat per-compound pricing models, PlexusDx's flat monthly rate ensures that optimizing your treatment remains financially predictable and accessible
US$ 21.89
US$ 27.47
US$ 25.60
US$ 22.29
